Rosalind Advisors Inc. Invests $1.49 Million in Alpha Cognition, Inc. (NASDAQ:ACOG)

Posted by Chris Copeland on Mar 22nd, 2025

Rosalind Advisors Inc. purchased a new stake in Alpha Cognition, Inc. (NASDAQ:ACOG – Free Report) during the 4th quarter, HoldingsChannel reports. The fund purchased 252,753 shares of the company’s stock, valued at approximately $1,489,000. Alpha Cognition makes up approximately 0.7% of Rosalind Advisors Inc.’s holdings, making the stock its 22nd largest position.

Analyst Ratings Changes

Separately, HC Wainwright began coverage on Alpha Cognition in a report on Tuesday. They set a “buy” rating and a $20.00 price objective for the company.

Check Out Our Latest Report on Alpha Cognition

Alpha Cognition Stock Performance

NASDAQ:ACOG opened at $5.37 on Friday. The firm has a market capitalization of $86.03 million, a price-to-earnings ratio of -2.10 and a beta of 2.50. Alpha Cognition, Inc. has a 12 month low of $4.66 and a 12 month high of $7.00. The company has a 50-day moving average price of $5.90.

About Alpha Cognition

(Free Report)

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.